Jorge Carrillo
Overview
Explore the profile of Jorge Carrillo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
131
Citations
2333
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Molina Molina E, Bech-Serra J, Franco-Trepat E, Jarne I, Perez-Zsolt D, Badia R, et al.
Nat Commun
. 2025 Feb;
16(1):1087.
PMID: 39920115
Plitidepsin is an antitumoral compound safe for treating COVID-19 that targets the translation elongation factor eEF1A. Here we detect that plitidepsin decreases de novo cap-dependent translation of SARS-CoV-2 and non-viral...
2.
Gualdron-Lopez M, Ayllon-Hermida A, Cortes-Serra N, Resa-Infante P, Bech-Serra J, Aparici-Herraiz I, et al.
Front Cell Infect Microbiol
. 2024 Nov;
14:1442743.
PMID: 39569406
Extracellular vesicles (EVs) released by virus-infected cells have the potential to encapsulate viral peptides, a characteristic that could facilitate vaccine development. Furthermore, plasma-derived EVs may elucidate pathological changes occurring in...
3.
Moron-Lopez S, Riveira-Munoz E, Urrea V, Gutierrez-Chamorro L, Avila-Nieto C, Noguera-Julian M, et al.
Microbiol Spectr
. 2024 Oct;
:e0226924.
PMID: 39475270
No abstract available.
4.
Panisello C, Aschero R, Martinez-Moreno A, Roca Ho H, Falgas A, Gonzalez-Navarro E, et al.
J Immunother Cancer
. 2024 Oct;
12(10).
PMID: 39379097
Humanized immunodeficient mice serve as critical models for investigating the functional interplay between transplanted human cells and a pre-reconstituted human immune system. These models facilitate the study of molecular and...
5.
Gutierrez-Valdes N, Cunyat F, Balieu J, Walet-Balieu M, Paul M, de Groot J, et al.
N Biotechnol
. 2024 Aug;
83:142-154.
PMID: 39142626
Multifunctional anti-HIV Fc-fusion proteins aim to tackle HIV efficiently through multiple modes of action. Although results have been promising, these recombinant proteins are hard to produce. This study explored the...
6.
Ortiz R, Barajas A, Pons-Grifols A, Trinite B, Tarres-Freixas F, Rovirosa C, et al.
Viruses
. 2024 Jun;
16(6).
PMID: 38932278
The envelope glycoprotein (Env) of retroviruses, such as the Feline leukemia virus (FeLV), is the main target of neutralizing humoral response, and therefore, a promising vaccine candidate, despite its reported...
7.
Moraes-Cardoso I, Benet S, Carabelli J, Perez-Zsolt D, Mendoza A, Rivero A, et al.
Lancet Microbe
. 2024 Jun;
5(8):100859.
PMID: 38857615
Background: Since the emergence of the global mpox outbreak in May, 2022, more than 90 000 cases have been diagnosed across 110 countries, disproportionately affecting people with HIV. The durability...
8.
Trinite B, Durr E, Pons-Grifols A, ODonnell G, Aguilar-Gurrieri C, Rodriguez S, et al.
Vaccine
. 2024 Apr;
42(15):3474-3485.
PMID: 38641492
Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) vaccines have been long overdue. Structure-based vaccine design created a new momentum in the last decade, and the first RSV vaccines have...
9.
Tarres-Freixas F, Clotet B, Carrillo J, Blanco J
Vaccines (Basel)
. 2024 Mar;
12(3).
PMID: 38543932
The development of HIV prophylactic vaccines is facing an impasse, since all phase IIb/III clinical trials were halted in 2023 without demonstrating efficacy. Thus, the field is in need of...
10.
Avila-Nieto C, Vergara-Alert J, Amengual-Rigo P, Ainsua-Enrich E, Brustolin M, Rodriguez de la Concepcion M, et al.
Nat Commun
. 2024 Mar;
15(1):2349.
PMID: 38514609
Safe and effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are crucial to fight against the coronavirus disease 2019 pandemic. Most vaccines are based on a mutated version of...